Risk Evaluation and Education for Alzheimer's Disease

Completed · Not applicable

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to determine the characteristics of those who obtain genetic susceptibility testing for Alzheimer's disease with APOE disclosure and to study the psychological and behavioral consequences of providing this information.

Key facts

Study ID

NCT00571025

Run by

National Human Genome Research Institute (NHGRI)

People needed

301

Starts

2000-08-01

Expected to finish

2004-04-01

Last updated by the study team

2009-07-23

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult children of a person with clinically diagnosed and/or autopsy-confirmed Alzheimer's disease
• 18 years or older

You may not qualify if…

• Current dementia
• Current untreated depression

Where it is running

• Boston University School of Medicine — Boston, Massachusetts, United States
• Weill Medical College of Cornell University — New York, New York, United States
• Case Western Reserve University — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.